Cardiol Therapeutics
Dolly Kao has extensive work experience in the field of intellectual property law. Dolly is currently a Shareholder and Chief IP Counsel at Dolly Kao Professional Corporation (Kao IP) and Virox Technologies Inc. respectively. Dolly previously held the same position at Cardiol Therapeutics Inc. Dolly co-founded and served as Counsel at Perry + Currier Inc. / Currier + Kao LLP and worked as an Associate at Ridout & Maybee LLP, Torys LLP, Barrigar & Moss, and Rogers & Scott.
Dolly Kao earned a Bachelor of Science degree in Nutritional Sciences from the University of Toronto in 1991. Dolly then pursued a Doctor of Law - JD degree from the same university, completing it in 1994. Dolly Kao has also obtained additional certifications including being a Registered Trademark Agent and a Registered Patent Agent from CPATA/CIPO in 1999 and 1998, respectively. Additionally, they became a Barrister and Solicitor, being called to the Bar of Ontario by the Law Society of Ontario in 1996.
This person is not in any teams
Cardiol Therapeutics
Cardiol Therapeutics Inc. is a clinical-stage biotechnology company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease.